Literature DB >> 33008614

Is same-day discharge associated with increased 30-day postoperative complications and readmissions in patients undergoing laparoscopic adrenalectomy?

Omair A Shariq1, Katherine A Bews2, Nicholas P McKenna3, Benzon M Dy3, Melanie L Lyden3, David R Farley3, Geoffrey B Thompson3, Travis J McKenzie3, Elizabeth B Habermann2.   

Abstract

BACKGROUND: Advances in minimally invasive surgery and perioperative care have decreased substantially the duration of time that patients spend recovering in hospital, with many laparoscopic procedures now being performed on an ambulatory basis. There are limited studies, however, on same-day discharge after laparoscopic adrenalectomy. The objectives of this study were to investigate the outcomes and trends of ambulatory laparoscopic adrenalectomy in a multicenter cohort of patients.
METHODS: Adult patients who underwent elective laparoscopic adrenalectomy between 2005 and 2016 were identified in the database of the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). Baseline demographics and 30-day outcomes were compared between patients who underwent ambulatory laparoscopic adrenalectomy and those who were discharged after an inpatient stay. Multivariable logistic regression and Cox proportional hazards modelling were used to investigate the association between same-day discharge and 30-day complications and unplanned readmissions.
RESULTS: Of the 4,807 patients included in the study, 88 (1.8%) underwent ambulatory laparoscopic adrenalectomy and 4,719 (98.2%) were admitted after the adrenalectomy. The same-day discharge group contained fewer obese patients (37.2% vs 50%; P = .04), a lesser proportion of American Society of Anesthesiologists class III patients (45.5% vs 61%; P = .003), and more patients with primary aldosteronism (14.8% vs 6%; P = .002) compared with the inpatient group. After adjustment for confounders, same-day discharge was not associated with 30-day overall complications (OR 1.17, 95% CI 0.35-3.85; P = .80) or unplanned readmissions (HR 2.77, 95% CI 0.86-8.96; P = .09). The percentage of laparoscopic adrenalectomies performed on an ambulatory basis at hospitals participating in the ACS NSQIP remained low throughout the study period (0-3.1% per year) with no evidence of an increasing trend over time (P = .21).
CONCLUSION: Ambulatory laparoscopic adrenalectomy is a safe and feasible alternative to inpatient hospitalization in selected patients. Further study is needed to determine the cost savings, barriers to uptake, and optimal selection criteria for this approach.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 33008614     DOI: 10.1016/j.surg.2020.08.018

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  5 in total

1.  National perspective on hospital readmissions following adrenalectomy.

Authors:  Mohammed Hussein; Eman Toraih; Ahmed Mahmoud Fouad; Lauren Mueller; Alexander Blum; Zaid Al-Qurayshi; Jeffrey Borchardt; Emad Kandil
Journal:  Gland Surg       Date:  2022-06

2.  Same-day discharge following minimally invasive partial and radical nephrectomy: a National Surgical Quality Improvement Program (NSQIP) analysis.

Authors:  Krishna Teja Ravivarapu; Evan Garden; Chih Peng Chin; Micah Levy; Osama Al-Alao; Joseph Sewell-Araya; Alexander Small; Reza Mehrazin; Michael Palese
Journal:  World J Urol       Date:  2022-07-30       Impact factor: 3.661

3.  Unilateral Adrenalectomy for Primary Aldosteronism Due to Bilateral Adrenal Disease Can Result in Resolution of Hypokalemia and Amelioration of Hypertension.

Authors:  Thomas Szabo Yamashita; Omair A Shariq; Trenton R Foster; Melanie L Lyden; Benzon M Dy; William F Young; Irina Bancos; Travis J McKenzie
Journal:  World J Surg       Date:  2022-10-07       Impact factor: 3.282

4.  Factors contributing to readmissions after laparoscopic adrenalectomy.

Authors:  Maciej Sebastian
Journal:  Gland Surg       Date:  2022-07

Review 5.  Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment.

Authors:  Omair A Shariq; Travis J McKenzie
Journal:  Ther Adv Chronic Dis       Date:  2021-07-20       Impact factor: 5.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.